Neuberger Berman Group LLC Amicus Therapeutics, Inc. Transaction History

Neuberger Berman Group LLC

$118 Billion
Q1 2024

A detailed history of Neuberger Berman Group LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 468,652 shares of FOLD stock, worth $4.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

468,652

Holding current value

$4.82 Million

% of portfolio

0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$11.43 - $14.24 $5.36 Million - $6.67 Million	468,652 New	468,652 $5.52 Million
Q4 2023 Feb 09, 2024	BUY	$9.97 - $14.52 $1.71 Million - $2.48 Million	171,029 Added 31.28%	717,714 $10.2 Million
Q3 2023 Nov 14, 2023	BUY	$11.78 - $13.86 $49,476 - $58,212	4,200 Added 0.77%	546,685 $6.65 Million
Q2 2023 Aug 11, 2023	BUY	$10.72 - $13.3 $2.33 Million - $2.89 Million	217,430 Added 66.89%	542,485 $6.81 Million
Q1 2023 May 12, 2023	BUY	$10.91 - $13.54 $161,675 - $200,649	14,819 Added 4.78%	325,055 $3.6 Million

Q4 2022 Feb 13, 2023	SELL	$9.89 - $12.7 $1.6 Million - $2.06 Million	-162,158 Reduced 34.33%	310,236 $3.79 Million
Q3 2022 Nov 15, 2022	SELL	$9.82 - $12.75 $35,440 - $46,014	-3,609 Reduced 0.76%	472,394 $4.93 Million
Q2 2022 Aug 15, 2022	BUY	$6.23 - $11.12 $199,528 - $356,140	32,027 Added 7.21%	476,003 $5.11 Million
Q1 2022 May 13, 2022	BUY	$7.89 - $12.48 $115,265 - $182,320	14,609 Added 3.4%	443,976 $4.2 Million
Q4 2021 Feb 11, 2022	BUY	$9.82 - $12.44 $4.22 Million - $5.34 Million	429,367 New	429,367 $4.87 Million
Q1 2021 May 13, 2021	SELL	$9.2 - $23.86 $1.5 Million - $3.89 Million	-163,011 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$13.47 - $24.89 $902,341 - $1.67 Million	-66,989 Reduced 29.13%	163,011 $3.76 Million
Q2 2020 Aug 13, 2020	BUY	$8.86 - $15.69 $88,600 - $156,900	10,000 Added 4.55%	230,000 $3.47 Million
Q4 2019 Feb 12, 2020	SELL	$7.48 - $10.75 $690,404 - $992,225	-92,300 Reduced 29.55%	220,000 $2.14 Million
Q3 2019 Nov 13, 2019	SELL	$8.02 - $13.25 $160,400 - $265,000	-20,000 Reduced 6.02%	312,300 $2.51 Million
Q2 2019 Aug 13, 2019	BUY	$10.96 - $14.4 $1.34 Million - $1.76 Million	122,300 Added 58.24%	332,300 $4.15 Million
Q1 2019 May 13, 2019	BUY	$10.04 - $13.92 $240,959 - $334,080	24,000 Added 12.9%	210,000 $2.86 Million
Q4 2018 Feb 12, 2019	BUY	$8.38 - $13.44 $469,280 - $752,640	56,000 Added 43.08%	186,000 $1.78 Million
Q3 2018 Nov 13, 2018	BUY	$11.6 - $16.54 $464,000 - $661,600	40,000 Added 44.44%	130,000 $1.57 Million
Q2 2018 Aug 13, 2018	BUY	$13.13 - $17.09 $393,900 - $512,700	30,000 Added 50.0%	90,000 $1.41 Million
Q1 2018 May 08, 2018	SELL	$13.76 - $17.12 $82,560 - $102,720	-6,000 Reduced 9.09%	60,000 $902,000
Q4 2017 Feb 14, 2018	BUY	$12.51 - $16.24 $663,030 - $860,719	53,000 Added 407.69%	66,000 $950,000
Q3 2017 Nov 15, 2017	BUY	$11.74 - $15.78 $152,620 - $205,140	13,000	13,000 $196,000

Others Institutions Holding FOLD

# of Institutions

276

Shares Held

326M

Call Options Held

841K

Put Options Held

353K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.88B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Amicus Therapeutics, Inc. Transaction History